Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
17%

OVERLAP
BY WEIGHT
14

# OF OVERLAPPING
HOLDINGS
SBIO
86
HOLDINGS
16%
ALSO IN IBRN
IBRN
73
HOLDINGS
29%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus IBRN)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in SBIO
Weight
in IBRN
Overlap
DIANTHUS THERAPEUTICS INC 3.0% 5.2% 3.0%
ACADIA PHARMACEUTICALS INC 2.5% 5.0% 2.5%
EDGEWISE THERAPEUTICS, INC. 2.4% 3.5% 2.4%
DYNE THERAPEUTICS INC 2.1% 3.4% 2.1%
DENALI THERAPEUTICS INC. 2.0% 3.7% 2.0%
SBIO Overweight Relative to IBRN
CRINETICS PHARMACEUTICALS INC 4.4%
APOGEE THERAPEUTICS, INC. 4.1%
CG ONCOLOGY, INC. 3.5%
ORUKA THERAPEUTICS INC 3.2%
TRAVERE THERAPEUTICS, INC. 3.0%
DEFINIUM THERAPEUTICS INC 2.4%
AMYLYX PHARMACEUTICALS, INC. 2.1%
VERADERMICS INC 2.1%
RELAY THERAPEUTICS, INC. 2.1%
IDEAYA BIOSCIENCES, INC. 1.7%
SBIO Underweight Relative to IBRN
SCHOLAR ROCK HOLDING CORP. -4.8%
ARROWHEAD PHARMACEUTICALS, INC. -4.5%
ARGENX SE ADR -4.4%
ALKERMES PLC -4.2%
BIOGEN IDEC INC -4.1%
PTC THERAPEUTICS INC -3.7%
NEUROCRINE BIOSCIENCES INC -3.5%
AXSOME THERAPEUTICS, INC. -3.3%
AXOGEN, INC. -2.6%
SUPERNUS PHARMACEUTICALS INC -2.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY